Form 8-K - Current report:
SEC Accession No. 0001493152-25-008137
Filing Date
2025-02-25
Accepted
2025-02-25 07:30:12
Documents
17
Period of Report
2025-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52220
2 ex4-1.htm EX-4.1 102861
3 ex4-2.htm EX-4.2 97475
4 ex10-1.htm EX-10.1 548936
5 ex99-1.htm EX-99.1 12903
  Complete submission text file 0001493152-25-008137.txt   1153366

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE maia-20250224.xsd EX-101.SCH 3024
7 XBRL LABEL FILE maia-20250224_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE maia-20250224_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3784
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 25659406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)